Literature DB >> 3492690

Neuromelanic pigment in substantia nigra neurons of rats and dogs.

M DeMattei, A C Levi, R G Fariello.   

Abstract

The presence of neuromelanic pigment in neurons of the rat substantia nigra (SN) is a matter of controversy. The presence of neuromelanin in the SN of 15--24-month-old rats was investigated by electron microscopy (EM) and the findings compared to the morphology and distribution of neuromelanin in SN of dogs. In the rat, EM examination revealed a few small, evenly distributed neuromelanic granules in only 5% of nigral neurons. Dogs of 1 year of age showed a similar pattern; however, SN from adult and aged dogs exhibited abundant and larger neuromelanin granules which were also detectable by light microscopy. It is concluded that scanty neuromelanin is detectable by EM in rat SN and that the content of this pigment increases with age. The documented paucity of neuromelanin in rat SN neurons may explain why higher doses and longer treatment with MPTP is required in rats to obtain biochemical and behavioral signs of nigrostriatal dysfunction in this species.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3492690     DOI: 10.1016/0304-3940(86)90614-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

Review 1.  Neuromelanin of the human substantia nigra: an update.

Authors:  Fabio A Zucca; Emy Basso; Francesca A Cupaioli; Emanuele Ferrari; David Sulzer; Luigi Casella; Luigi Zecca
Journal:  Neurotox Res       Date:  2013-10-24       Impact factor: 3.911

Review 2.  Neuromelanin in Parkinson's Disease: from Fenton Reaction to Calcium Signaling.

Authors:  Rainer Knörle
Journal:  Neurotox Res       Date:  2017-09-06       Impact factor: 3.911

Review 3.  Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour.

Authors:  L Zecca; D Tampellini; M Gerlach; P Riederer; R G Fariello; D Sulzer
Journal:  Mol Pathol       Date:  2001-12

4.  Evidence for Dopamine Abnormalities Following Acute Methamphetamine Exposure Assessed by Neuromelanin-Sensitive Magnetic Resonance Imaging.

Authors:  Fei Tang; Hui Liu; Xiao Jie Zhang; Hui Hui Zheng; Yong Ming Dai; Li Yun Zheng; Wen Han Yang; Yan Yao Du; Jun Liu
Journal:  Front Aging Neurosci       Date:  2022-05-30       Impact factor: 5.702

Review 5.  The effect of L-deprenyl on behavior, cognitive function, and biogenic amines in the dog.

Authors:  N W Milgram; G O Ivy; E Head; M P Murphy; P H Wu; W W Ruehl; P H Yu; D A Durden; B A Davis; I A Paterson
Journal:  Neurochem Res       Date:  1993-12       Impact factor: 3.996

Review 6.  Neuroprotection by immunomodulatory agents in animal models of Parkinson's disease.

Authors:  Bridget Martinez; Philip V Peplow
Journal:  Neural Regen Res       Date:  2018-09       Impact factor: 5.135

7.  Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles.

Authors:  D Sulzer; J Bogulavsky; K E Larsen; G Behr; E Karatekin; M H Kleinman; N Turro; D Krantz; R H Edwards; L A Greene; L Zecca
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

Review 8.  Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models.

Authors:  Andrea Capucciati; Fabio A Zucca; Enrico Monzani; Luigi Zecca; Luigi Casella; Tim Hofer
Journal:  Antioxidants (Basel)       Date:  2021-05-21

9.  Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiology.

Authors:  Stefania Romeo; Cristina Viaggi; Daniela Di Camillo; Allison W Willis; Luca Lozzi; Cristina Rocchi; Marta Capannolo; Gabriella Aloisi; Francesca Vaglini; Rita Maccarone; Matteo Caleo; Cristina Missale; Brad A Racette; Giovanni U Corsini; Roberto Maggio
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.